{
    "2018-06-14": [
        [
            {
                "time": "2018-06-14",
                "original_text": "[领先大市-B评级]医药行业动态分析：四价流感病毒裂解疫苗获批上市 国内流感疫苗布局进一步完善",
                "features": {
                    "keywords": [
                        "四价流感病毒裂解疫苗",
                        "获批上市",
                        "流感疫苗",
                        "布局完善"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-06-14",
                "original_text": "医药行业中期策略：聚焦服务、优质医药、商业三条主线(附股)",
                "features": {
                    "keywords": [
                        "医药行业",
                        "中期策略",
                        "服务",
                        "优质医药",
                        "商业主线"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-14",
                "original_text": "6月14日券商晨会研报汇编",
                "features": {
                    "keywords": [
                        "券商晨会",
                        "研报汇编"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-06-14",
                "original_text": "[增持评级]医药生物行业事件点评：四价流感疫苗获批生产 预防流感疫情并拉动相关公司业绩增长",
                "features": {
                    "keywords": [
                        "四价流感疫苗",
                        "获批生产",
                        "预防流感",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-06-14",
                "original_text": "【东吴晨报0614】【固收】社融回落点评【行业】医药【个股】利安隆、成实外教育、康尼机电",
                "features": {
                    "keywords": [
                        "东吴晨报",
                        "固收",
                        "社融回落",
                        "医药",
                        "利安隆",
                        "成实外教育",
                        "康尼机电"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-06-14",
                "original_text": "四价流感疫苗获批准入市场：流感疫苗市场格局生变",
                "features": {
                    "keywords": [
                        "四价流感疫苗",
                        "获批准入",
                        "市场格局",
                        "变化"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}